Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Prevention |
RCV000251682 | SCV000313367 | benign | not specified | criteria provided, single submitter | clinical testing | ||
Gene |
RCV001668562 | SCV001884932 | benign | not provided | 2018-07-09 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002347963 | SCV002619729 | benign | Cardiovascular phenotype | 2018-12-04 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Genome Diagnostics Laboratory, |
RCV000251682 | SCV001977789 | benign | not specified | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV001668562 | SCV001978037 | likely benign | not provided | no assertion criteria provided | clinical testing |